Lisata Therapeutics(LSTA) - 2023 Q4 - Annual Results

Exhibit 99.1 Lisata Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update "2023 was a testament to our unwavering commitment to operational excellence and focused, efficient development. Our entire organization worked seamlessly to achieve significant milestones in the advancement of our lead investigational product, LSTA1," stated David J. Mazzo, Ph.D., President and Chief Executive Officer of Lisata. "Throughout 2024, we look to maintain and even build on this momentum as we p ...